Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Research Ayala's ex-BMS drug shows promise in triple-negative breast cancer
Fierce Biotech
Sun, 06/2/19 - 01:28 pm
Tags:
ASCO 2019, Ayala Pharmaceuticals, Novartis, triple negative breast cancer, AL101
ASCO 2019 day three
Pharmaforum
Sun, 06/2/19 - 01:09 pm
Tags:
ASCO 2019, Merck, AstraZeneca, pancreatic cancer, Novartis, alpelisib, Roche, entrectinib
ASCO 2019 day two
Pharmaforum
Sun, 06/2/19 - 01:01 pm
Tags:
Gilead Sciences, Kite Pharma, KTE-X19, CAR-T, ASCO 2019, Novartis, Merck, Keytruda, spartalizumab
ASCO: Novartis' Kisqali posts first-in-class survival win in younger women
Fierce Pharma
Sat, 06/1/19 - 12:45 pm
Tags:
breast cancer, ASCO 2019, Novartis, clinical trials, Kisqali
Why Concerns About a “Break Down” in Drug Pricing Are Misplaced
BIOTechNow
Sat, 06/1/19 - 12:40 pm
Tags:
FDA, Novartis, drug pricing
Is the $2.1 Million Price Tag for Novartis' Zolgensma Ridiculous?
Motley Fool
Fri, 05/31/19 - 11:53 pm
Tags:
Novartis, Zolgensma, SMA, gene therapy
Novartis burnishes prospects for its big asthma drug with positive PhIII data from a similar treatment
Endpoints
Thu, 05/30/19 - 10:07 am
Tags:
Novartis, asthma, QMF149, clinical trials
ASCO 2019 Preview: Presentations to Keep An Eye On
BioSpace
Thu, 05/30/19 - 09:35 am
Tags:
ASCO 2019, Novartis, Oncoceutics, OncoNano Medicine, AstraZeneca
Novartis powers Notch cancer biotech Ayala to $30M series B
Fierce Biotech
Wed, 05/29/19 - 10:28 am
Tags:
Novartis, Ayala Pharmaceuticals, AL101, adenoid cystic carcinoma
FDA Approves First NDA Under Real-Time Oncology Review Pilot
RAPS.org
Tue, 05/28/19 - 11:15 pm
Tags:
FDA, Novartis, oncology, Real Time Oncology Review, Piqray
Novartis gets FDA nod for advanced breast-cancer treatment
Marketwatch
Sun, 05/26/19 - 11:19 am
Tags:
Novartis, FDA, advanced breast cancer, Piqray
Novartis on goal to hit mid-30s margins by 2022
BioCentury
Sun, 05/26/19 - 11:15 am
Tags:
Novartis, M&A
Novartis gene therapy approved, but will come at cost of more than $2 million
Biopharma Dive
Fri, 05/24/19 - 11:45 pm
Tags:
SMA, Novartis, drug pricing, Zolgensma
Novartis’ inhaled asthma combo QVM149 succeeds in two phase 2 trials
Pharmaceutical Business Review
Fri, 05/24/19 - 10:34 am
Tags:
Novartis, QVM149, clinical trials, asthma
Novartis chief Vas Narasimhan wants you to know about the '25-plus’ blockbusters he has in the pipeline
Endpoints
Thu, 05/23/19 - 12:46 pm
Tags:
Novartis, R&D, Sandoz, Pharma CEOs, Vas Narasimhan
Novartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range
Yahoo/Reuters
Thu, 05/23/19 - 09:48 am
Tags:
Novartis, Pharma CEOs, Vas Narasimhan, gene therapy, SMA, drug pricing, Zolgensma
Novartis' asthma triplet beats GSK's Advair in phase 2 trial
Fierce Pharma
Wed, 05/22/19 - 10:51 am
Tags:
Novartis, asthma, QVM149, GSK, Advair, clinical trials
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Tue, 05/21/19 - 11:07 pm
Tags:
Verily, Alphabet, clinical trials, Pfizer, Novartis, Sanofi, Otsuka
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 05/19/19 - 03:59 pm
Tags:
Incyte, Novartis, Athersys, ResTORbio, Bellerophon Therapeutics, Eli Lilly, CymaBay, Bicycle Therapeutics, Peloton Therapeutics, Ideaya, IPOs
GSK and Novartis liniment marketing misled Australian consumers: court
Reuters
Sat, 05/18/19 - 08:46 pm
Tags:
GSK, Novartis, Australia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.